Ovarian Cancer
Researchers from Southern Medical University report details of new studies and findings in the area of ovarian cancer
Published in Cancer Weekly, June 24th, 2008
New research, 'Silencing of ZNF217 gene influences the biological behavior of a human ovarian cancer cell line,' is the subject of a report. According to recent research published in the International Journal of Oncology, "Zinc-finger protein 217 (ZNF217), a candidate oncogene on 20q13.2, can lead cultured human ovarian and mammary epithelial cells to immortalization, which indicates selective expression of ZNF217 affecting 20q13 amplification during critical early stages of cancer progression. In this study, we tested the hypothesis that ZNF217 is a key factor in regulating ovarian cancer proliferation and progression."
"We examined the effect of the inhibition...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-06-24)
More Articles from Cancer Weekly
- Cure Lab, Inc.
A protein sequence associated with Huntington's disease may become life-saving vaccine component - Research
Outing the outliers: Strategy matches oncogene with subtype of prostate cancer - Cancer Gene Therapy
Reports outline cancer gene therapy research from Kaohsiung Medical University - Cancer Gene Therapy
Reports summarize cancer gene therapy research from University of Michigan, Medical Department - Cancer Gene Therapy
Scientists at Wuhan University describe research in cancer gene therapy - Cancer Gene Therapy
Study results from National Cancer Institute in the area of cancer gene therapy published - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
